Assist. Prof. Dr. Alireza Ghannad Sabzevari is an accomplished researcher with a PhD in Nanobiotechnology from the University of Tehran 🎓. His groundbreaking work on montmorillonite nanoparticles has revolutionized cancer therapy, particularly for chemo/radio-resistant tumors 🧬. Dr. Sabzevari’s research enhances drug delivery systems and improves bioavailability of anticancer compounds, offering novel solutions in cancer treatment 💡. He has led several impactful projects at institutions like the Cancer Research Center and Shariati Hospital, and is recognized for his leadership in both academia and the scientific community 🌍. His innovative contributions make him a leader in nanotechnology and cancer research 🏆.
Assist. Prof. Dr Alireza Ghannad Sabzevari, Hamadan University of Medical Sciences, Iran
Profile
GOOGLE SCHOLAR
Academic and Professional Excellence 🎓🔬
Assist. Prof. Dr. Alireza Ghannad Sabzevari holds a Master of Science in Biotechnology and a PhD in Nanobiotechnology, graduating with top honors 🎓. Ranked 3rd in his Master’s program and 1st in his PhD at the University of Tehran, his work on “Montmorillonite, a nanoparticle with intrinsic cancer inhibitory activity” earned international recognition 🌍. Nominated as one of the top 8 works at the 25th ISCOMS in 2018, he has held leadership roles, including chairman at an inspection company, senior expert at a medical diagnostic lab, and director at Hamadan University of Medical Sciences, where he currently serves at the Cancer Research Center 🧬✨.
Expertise 🧬💡
Assist. Prof. Dr. Alireza Ghannad Sabzevari specializes in cancer therapy and drug delivery using nanotechnology 🧫💉. His research focuses on leveraging the potential of nanotechnology to develop innovative cancer treatments and efficient drug delivery systems 🎯. With a strong background in biotechnology and nanobiotechnology, his work aims to revolutionize the medical field, providing advanced solutions for cancer therapy and targeted drug delivery 🚀🔬. Dr. Ghannad Sabzevari’s contributions to these cutting-edge areas continue to pave the way for groundbreaking advancements in medical research and therapeutic applications 🌱✨.
Research and Innovations🧬💡
Assist. Prof. Dr. Alireza Ghannad Sabzevari is pioneering the use of Montmorillonite (Mt) nanoclays for cancer therapy. His research demonstrates Mt’s antiproliferative effects on aggressive, chemo/radio-resistant cancer cells like MDA-MB-231 breast cancer cells 🧪🎯. His innovative work also explores Mt as a nanocarrier, enhancing the bioavailability of anticancer compounds like punicalagin from pomegranate peel 🌿🍊. His groundbreaking findings offer promising solutions for local and systemic cancer treatments, aiming to improve the efficacy of existing therapies and provide new approaches for inoperable and aggressive tumors 🚀🔬.
Publication Top Notes
Montmorillonite, a natural biocompatible nanosheet with intrinsic antitumor activity
Development and characteristics of layered EGCG/Montmorillonite hybrid: An oral controlled-release formulation of EGCG
Montmorillonite an efficient oral nanocarrier for punicalagin-rich pomegranate peel extract: An in vitro study
A quick, efficient, and cost-effective method for isolating high-quality total RNA from tomato fruits, suitable for molecular biology studies
Two main domains with different roles discovered a new tomato beta-galactosidase.
Investigating the Cytotoxicity of Montmorillonite Nanoparticles as a Carrier for Oral Drug Delivery Systems